Page 3 - Multiple Sclerosis Ms News Today

Depression, constipation, cystitis, urinary tract infections, and sexual dysfunction may precede a diagnosis of multiple sclerosis by 5 years, new research shows.

Despite higher up-front costs, enhanced home blood pressure monitoring by hypertension patients could be cost-effective compared with standard clinical care.

Roches Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.

Measuring levels of neurofilament light chain in the blood could warn of worsening disability up to 2 years before it occurs.

COVID-19 has no impact on disease activity, progression, or cognitive performance in patients with multiple sclerosis.

Bristol Myers Squibb on Thursday pushed back by a year the time frame for its new-product portfolio to hit $10 billion in revenue as the sales ramp-up of medicines such as psoriasis treatment Sotyktu and multiple sclerosis drug Zeposia takes longer than initially projected.

Researchers are exploring HSCT as a rescue therapy in early-stage MS. But theres no consensus on best practices.

Anti-CD20 antibody therapy can be effectively and safely administered subcutaneously to patients with MS, even when switching from a prior treatment, two clinical trials suggest.

Neurologist Jeremy Chataway brings you the latest on important clinical trials in progressive MS that will help guide the field toward better treatments.

A neurology professor talks about the need to identify early biomarkers of MS, describes a three-stage model for the disease, and ponders how to define cure in this setting.